Address of Corresponding Author

Intervirology 2005;48:161-166 (DOI: 10.1159/000081744)

  Key Words

• Dengue-2-virus
• Full-length cDNA
• Suckling mice system

  Abstract

Objective: In this study we established a mouse brain injection system to detect infectious dengue-2 virus produced from the full-length RNA transcripts.Methods: In vitrotranscription was usedto synthesizefull-length dengue-2 virus RNA from the plasmid pRS424FLDEN2NGC, which was intracerebrally injected into the 6-day-old suckling mice (ICR strains). Engineered dengue-2 viruses were detected in the brain sections using immunohistochemistry staining. RT-PCR followed by restriction endonuclease BstEII digestion was used to confirm the mosquito C6/36 cells cocultured with the mouse brain extract. Results: The mice inoculated with the full-length dengue-2 viral RNA transcript showed paralysis symptoms and died between day 10 and 13 postinjection. The dengue-2 virus-specific antigens (E, Core and NS1) were detected in all the brain and part of the liver sections of the paralyzed mice by immunohistochemistry staining, indicating the existence of dengue-2 virus in these tissues of the suckling mice. The viruses detected in the brains of suckling mice were indeed infectious, which was further confirmed by coculturing mosquito C6/36 cells with the brain extract of the injected mice. Conclusions: Wedeveloped an in vivo approach to detect and produce engineered dengue viruses with infectivity from the full-length plasmid cDNA. This suckling mice system will also aid in screening the infectious viruses that are created by site-directed mutagenesis and is useful for the studies of dengue virus gene function and pathogenesis in the host.

Copyright © 2005 S. Karger AG, Basel

  References

1.

Monath TP: Dengue: The risk to developed and developing countries. Proc Natl Acad Sci USA 1994;91:2395-2400.

2.

Racaniello VR, Baltimore D: Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 1981;214:916-919.

3.

Lai CJ, Zhao BT, Hori H, Bray M: Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci USA 1991;88:5139-5143.

4.

Pur B, Polo S, Hayes CG, Falgout B: Construction of a full length infectious clone for dengue-1 virus Western Pacific, 74 strain. Virus Genes 2000;20:57-63.

5.

Kapoor M, Zhang L, Mohan PM, Padmanabhan R: Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain). Gene 1995;162:175-180.

6.

Polo S, Ketner G, Levis R, Falgout B: Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast. J Virol 1997;71:5366-5374.

7.

Meiklejohn G, England B, Lennette EH: Adaptation of dengue virus strains in unweaned mice. Am J Trop Med Hyg 1952;1:51-58.

8.

Schlesinger RW: Dengue viruses. Virol Monogr 1977:1-132.

9.

Dorrance WR, Frankel JW, Gordon I, Patterson PR, Schlesinger RW, Winter JW: Clinical and serologic response of man to immunization with attenuated dengue and yellow fever viruses. J Immunol 1956;77:352-364.

10.

Sabin AB, Schlesinger RW: Production of immunity to dengue with virus modified by propagation in mice. Science 1952;101:640-642.

11.

Gritsun TS, Gould EA: Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR. Virology 1995;214:611-618.

12.

Liu HS, Lin YL, Chen CC: Comparison of various methods of detection of different forms of dengue virus type 2 RNA in cultured cells. Acta Virol 1997;41:317-324.

13.

Lum LC, Lam SK, Choy YS, George R, Harun F: Dengue encephalitis: A true entity? Am J Trop Med Hyg 1996;54:256-259.

14.

Bray M, Lai CJ: Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci USA 1991;88:10342-10346.

15.

Chen W, Kawano H, Men R, Clark D, Lai CJ: Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J Virol 1995;69:5186-5190.

16.

Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ: Construction of infectious cDNA clones for dengue 2 virus: Strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 1997;230:300-308.

17.

An J, Zhou DS, Kawasaki K, Yasui K: The pathogenesis of spinal cord involvement in dengue virus infection. Virchows Arch 2003;442:472-481.

18.

Blaney JE Jr, Johnson DH, Manipon GG, Firestone CY, Hanson CT, Murphy BR, Whitehead SS: Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology 2002;300:125-139.

19.

Nogueira RM, Filippis AM, Coelho JM, Sequeira PC, Schatzmayr HG, Paiva FG, Ramos AM, Miagostovich MP: Dengue virus infection of the central nervous system (CNS): A case report from Brazil. Southeast Asian J Trop Med Public Health 2002;33:68-71.

20.

Burke T: Dengue haemorrhagic fever: A pathological study. Trans R Soc Trop Med Hyg 1968;62:682-692.

21.

Hall WC, Crowell TP, Watts DM, Barros VL, Kruger H, Pinheiro F, Peters CJ: Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg 1991;45:408-417.

22.

Rosen L, Khin MM, U T: Recovery of virus from the liver of children with fatal dengue: Reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol 1989;140:351-360.

23.

An J, Kimura-Kuroda J, Hirabayashi Y, Yasui K: Development of a novel mouse model for dengue virus infection. Virology 1999;263:70-77.

  Author Contacts

H.-S. Liu
Department of Microbiology and Immunology
College of Medicine, National Cheng Kung University
1 Da-Shue Road, Tainan 701 (Taiwan)
Tel. +886 6 235 3535, ext. 5630, Fax +886 6 208 2705, E-Mail a713@mail.ncku.edu.tw

  Article Information

Received: January 22, 2004
Accepted after revision: July 5, 2004
Number of Print Pages : 6
Number of Figures : 4, Number of Tables : 1, Number of References : 23

  Publication Details

Intervirology (International Journal of Basic and Medical Virology)

Vol. 48, No. 2-3, Year 2005 (Cover Date: March-June 2005)

Journal Editor: Liebert, U.G. (Leipzig)
ISSN: 0300-5526 (print), 1423-0100 (Online)

For additional information: http://www.karger.com/int

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.